StemCell Institute Inc. (7096.T)
JPY 1286.0
(-7.28%)
JPY 1286.0
(-7.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.85 Billion JPY | 9.61% |
| 2022 | 3.51 Billion JPY | 12.9% |
| 2021 | 3.11 Billion JPY | 18.03% |
| 2020 | 2.63 Billion JPY | 14.57% |
| 2019 | 2.3 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.92 Billion JPY | 2.04% |
| 2023 Q4 | 3.85 Billion JPY | 3.86% |
| 2023 Q3 | 3.7 Billion JPY | 1.15% |
| 2023 Q2 | 3.66 Billion JPY | 4.37% |
| 2023 Q1 | 3.51 Billion JPY | -0.04% |
| 2023 FY | 3.85 Billion JPY | 9.61% |
| 2022 Q3 | 3.31 Billion JPY | 2.72% |
| 2022 Q2 | 3.23 Billion JPY | 0.0% |
| 2022 Q4 | 3.51 Billion JPY | 5.83% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 3.24 Billion JPY | -18.588% |
| PRISM BioLab Co.,LTD | 63.41 Million JPY | -5972.23% |
| GNI Group Ltd. | 26.34 Billion JPY | 85.383% |
| Linical Co., Ltd. | 10.3 Billion JPY | 62.635% |
| Trans Genic Inc. | 3.81 Billion JPY | -0.995% |
| MEDINET Co., Ltd. | 590.2 Million JPY | -552.395% |
| Soiken Holdings Inc. | 697.02 Million JPY | -452.415% |
| Cytori Cell Research Institute, Inc. | 3.02 Billion JPY | -27.467% |
| AnGes, Inc. | 2.78 Billion JPY | -38.041% |
| OncoTherapy Science, Inc. | 513.6 Million JPY | -649.69% |
| Nxera Pharma Co., Ltd. | 90.38 Billion JPY | 95.74% |
| Immuno-Biological Laboratories Co., Ltd. | 353.27 Million JPY | -989.946% |
| NanoCarrier Co., Ltd. | 1.64 Billion JPY | -133.377% |
| Carna Biosciences, Inc. | 472.35 Million JPY | -715.163% |
| CanBas Co., Ltd. | 91.98 Million JPY | -4085.831% |
| D. Western Therapeutics Institute, Inc. | 1.09 Billion JPY | -252.089% |
| RaQualia Pharma Inc. | 809.83 Million JPY | -375.465% |
| Chiome Bioscience Inc. | 593.73 Million JPY | -548.52% |
| Kidswell Bio Corporation | 4.25 Billion JPY | 9.488% |
| PeptiDream Inc. | 29.11 Billion JPY | 86.775% |
| Oncolys BioPharma Inc. | 566.5 Million JPY | -579.693% |
| Ribomic Inc. | 155.8 Million JPY | -2371.271% |
| SanBio Company Limited | 2.25 Billion JPY | -70.76% |
| Healios K.K. | 11.28 Billion JPY | 65.883% |
| BrightPath Biotherapeutics Co., Ltd. | 251.26 Million JPY | -1432.406% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 369 Million JPY | -943.486% |
| Delta-Fly Pharma, Inc. | 241.49 Million JPY | -1494.414% |
| StemRIM | 187 Million JPY | -1959.071% |
| CellSource Co., Ltd. | 677.73 Million JPY | -468.133% |
| FunPep Company Limited | 189.32 Million JPY | -1933.795% |
| Kringle Pharma, Inc. | 596.95 Million JPY | -545.017% |
| Stella Pharma Corporation | 1.44 Billion JPY | -166.725% |
| TMS Co., Ltd. | 97.68 Million JPY | -3841.551% |
| Noile-Immune Biotech Inc. | 91.49 Million JPY | -4108.431% |
| Cuorips Inc. | 200.96 Million JPY | -1816.025% |
| K Pharma,Inc. | 209.13 Million JPY | -1741.146% |
| Takara Bio Inc. | 11.42 Billion JPY | 66.283% |
| ReproCELL Incorporated | 741.03 Million JPY | -419.608% |
| PhoenixBio Co., Ltd. | 917.71 Million JPY | -319.571% |
| Japan Tissue Engineering Co., Ltd. | 908.43 Million JPY | -323.858% |
| CellSeed Inc. | 301.04 Million JPY | -1179.024% |